GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » ANGLE PLC (OTCPK:ANPCF) » Definitions » Debt-to-Equity

ANGLE (ANPCF) Debt-to-Equity : 0.14 (As of Jun. 2023)


View and export this data going back to 2014. Start your Free Trial

What is ANGLE Debt-to-Equity?

ANGLE's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $0.77 Mil. ANGLE's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $5.00 Mil. ANGLE's Total Stockholders Equity for the quarter that ended in Jun. 2023 was $40.49 Mil. ANGLE's debt to equity for the quarter that ended in Jun. 2023 was 0.14.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for ANGLE's Debt-to-Equity or its related term are showing as below:

ANPCF' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02   Med: 0.06   Max: 0.16
Current: 0.14

During the past 13 years, the highest Debt-to-Equity Ratio of ANGLE was 0.16. The lowest was 0.02. And the median was 0.06.

ANPCF's Debt-to-Equity is ranked better than
64.47% of 197 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.22 vs ANPCF: 0.14

ANGLE Debt-to-Equity Historical Data

The historical data trend for ANGLE's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ANGLE Debt-to-Equity Chart

ANGLE Annual Data
Trend Apr13 Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.04 0.06 0.13

ANGLE Semi-Annual Data
Oct13 Apr14 Oct14 Apr15 Oct15 Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.06 0.16 0.13 0.14

Competitive Comparison of ANGLE's Debt-to-Equity

For the Diagnostics & Research subindustry, ANGLE's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ANGLE's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, ANGLE's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where ANGLE's Debt-to-Equity falls into.



ANGLE Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

ANGLE's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

ANGLE's Debt to Equity Ratio for the quarter that ended in Jun. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ANGLE  (OTCPK:ANPCF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


ANGLE Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of ANGLE's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


ANGLE (ANPCF) Business Description

Traded in Other Exchanges
Address
10 Nugent Road, The Surrey Research Park, Surrey, Guildford, GBR, GU2 7AF
ANGLE PLC is active in the healthcare sector in the United Kingdom. It is a medical diagnostic company specializing in the development of pioneering products in cancer diagnostics. Its patented Parsortix technology can potentially treat and diagnose various forms of cancer. The Parsortix system can capture and harvest CTCs from patient blood. Its geographical segments include Europe and North America, of which majority of its revenue is generated from Europe.

ANGLE (ANPCF) Headlines

From GuruFocus

Angle PLC Announces AACR 2019

By ACCESSWIRE AccessWire 04-12-2019

Angle PLC Announces Holding(s) in Company - (1)

By ACCESSWIRE ACCESSWIRE 07-08-2020

Angle PLC Announces Exercise of Options and Total Voting Rights

By ACCESSWIRE ACCESSWIRE 04-30-2021

Angle PLC Announces Holding(s) in Company - (2)

By ACCESSWIRE ACCESSWIRE 07-08-2020